Pharmacogenetics and pharmacogenomics: origin, status, and the hope for personalized medicine von Kalow, W

Volltext

A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene : association with tardive dyskinesia in schizophrenia von BASILE, V. S, ÖZDEMIR, V, KENNEDY, J. L, MASELLIS, M, WALKER, M. L, MELTZER, H. Y, LIEBERMAN, J. A, POTKIN, S. G, ALVA, G, KALOW, W, MACCIARDI, F. M

Volltext

Interethnic variation of drug metabolism von Kalow, Werner

Volltext

Both populations and individuals are evolutionary targets: pharmacogenomic and cultural indicators von Kalow, W

Volltext

Perspectives in pharmacogenetics von Kalow, W

Volltext

Intramuscular desferrioxamine in patients with Alzheimer's disease von McLachlan, D.R.C., Kruck, T.P.A., Kalow, W., Andrews, D.F., Dalton, A.J., Bell, M.Y., Smith, W.L.

Volltext

Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specific... von AOYAMA, T, YAMAMO, S, GONZALEZ, F. J, WAXMAN, D. J, LAPENSON, D. P, MEYER, U. A, FISCHER, V, TYNDALE, R, INABA, T, KALOW, W, GELBOIN, H. V

Volltext

Pharmacogenetics, pharmacogenomics, and pharmacobiology von Kalow, Werner

Volltext

Ethnic differences in drug metabolism von Kalow, W

Volltext

The science of pharmacological variability: An essay von Kalow, Werner, Ozdemir, Vural, Tang, Bing‐Kou, Tothfalusi, Laszlo, Endrenyi, Laszlo

Volltext

Pharmacokinetics of dextromethorphan and metabolites in humans : influence of the CYP2D6 phenotype and quinidine inhibition von SCHADEL, M, DAFANG WU, OTTON, V, KALOW, W, SELLERS, E. M

Volltext

Pharmacogenetics and personalised medicine von Kalow, Werner

Volltext

Genetic variation in the human hepatic cytochrome P-450 system von KALOW, W

Volltext

Pharmacogenetic research: a revolutionary science von Kalow, W

Volltext

A simple test for acetylator phenotype using caffeine von Grant, D.M., Tang, B.K., Kalow, W.

Volltext

Paroxetine steady-state plasma concentration in relation to CYP2D6 genotype in extensive metabolizers von Ozdemir, V, Tyndale, R F, Reed, K, Herrmann, N, Sellers, E M, Kalow, W, Naranjo, C A

Volltext

Neuronal cytochrome P450IID1 (debrisoquine/sparteine-type): potent inhibition of activity by (-)-cocaine and nucleotide sequence identity to human hepatic P450 gene CYP2D6 von TYNDALE, R. F, SUNHARA, R, INABA, T, KALOW, W, GONZALEZ, F. J, NIZNIK, H. B

Volltext

Oxidation of reduced haloperidol to haloperidol: involvement of human P450IID6 (sparteine/debrisoquine monooxygenase) von Tyndale, RF, Kalow, W., Inaba, T.

Volltext

Race and Therapeutic Drug Response von Kalow, W

Volltext

CYP2D6 and DRD2 genes differentially impact pharmacodynamic sensitivity and time course of prolactin response to perphenazine von Aklillu, Eleni, Kalow, Werner, Endrenyi, Laszlo, Harper, Patricia, Miura, Jun, Ozdemir, Vural

Volltext